Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir

PHASE3CompletedINTERVENTIONAL
Enrollment

881

Participants

Timeline

Start Date

June 14, 2012

Primary Completion Date

February 4, 2015

Study Completion Date

May 15, 2015

Conditions
Hepatitis C Virus
Interventions
BIOLOGICAL

Peginterferon Lambda-1a

Syringes, subcutaneous (SC), 180μg, Once weekly, 24 or 48 weeks depending on response

BIOLOGICAL

Peginterferon Alfa-2a

Syringes, SC, 180μg, Once weekly, 24 or 48 weeks depending on response

DRUG

Ribavirin

Tablets, Oral, 1000 or 1200 mg based on weight, twice daily, 24 or 48 weeks depending on response

DRUG

Telaprevir

Tablets, Oral, 750 mg, three times a day, 12 weeks only

Trial Locations (104)

1200

Local Institution, Brussels

2650

Local Institution, Edegem

3000

Local Institution, Leuven

4000

Local Institution, Liège

4010

Local Institution, Linz

4031

Local Institution, Basel

8036

Local Institution, Graz

8091

Local Institution, Zurich

10126

Local Institution, Torino

10969

Local Institution, Berlin

15006

Local Institution, A Coruña

15706

Local Institution, Santiago de Compostela

16100

Local Institution, Nazareth

18618

Local Institution, Botucatu

20014

Local Institution, Donostia / San Sebastian

20121

Local Institution, Milan

20246

Local Institution, Hamburg

21040

Local Institution, Rio de Janeiro

21202

Mercy Medical Center, Baltimore

22003

Metropolitan Research, Annandale

23502

Digestive And Liver Disease Specialists, Norfolk

23602

Bon Secours St. Mary'S Hospital Of Richmond, Inc., Newport News

24127

Local Institution, Bergamo

28204

Carolinas Medical Center, Charlotte

30060

Gastrointestinal Specialists Of Georgia Pc, Marietta

30625

Local Institution, Hanover

31059

Local Institution, Toulouse

31096

Local Institution, Haifa

32803

Orlando Va Medical Center, Orlando

32809

Orlando Clinical Research Center, Orlando

33614

Infectious Disease Research Institute, Inc., Tampa

34362

Local Institution, Haifa

35033

Local Institution, Rennes

35209

Birmingham Gastroenterology Associates, P.C., Birmingham

35294

The Kirklin Clinic, Birmingham

The University Of Alabama Of Birmingham, Birmingham

38138

Gastro One, Germantown

40110

Local Institution, Salvador

41013

Local Institution, Seville

41014

Local Institution, Seville

45067

Local Institution, Orléans

45122

Local Institution, Essen

48149

Local Institution, Münster

52621

Local Institution, Ramat Gan

56124

Local Institution, Cisanello (pisa)

60590

Local Institution, Frankfurt

63104

Saint Louis University, St Louis

64111

Saint Luke'S Transplant Specialists, Kansas City

74104

Options Health Research, Llc, Tulsa

74135

Healthcare Research Consultants, Tulsa

76012

Texas Clinical Research Institute, Arlington

76031

Local Institution, Rouen

78215

Alamo Medical Research, San Antonio

78234

Brooke Army Medical Center, Fort Sam Houston

80240

Local Institution, Curitiba

84123

Clinical Research Centers Of America, Murray

86021

Local Institution, Poitiers

89081

Local Institution, Ulm

90035

Local Institution, Porto Alegre

90048

Cedars Sinai Medical Center, Los Angeles

90073

Va Greater Los Angeles Healthcare System, Los Angeles

90505

South Bay Ge Medical Group, Torrance

90822

Va Long Beach Healthcare System, Long Beach

91031

Local Institution, Jerusalem

92801

Anaheim Clinical Trials Llc, Anaheim

92844

Sc Clinical Research, Inc., Garden Grove

94110

University Of California, San Francisco/Sf General Hospital, San Francisco

94804

Local Institution, Villejuif

105275

Local Institution, Moscow

107996

Local Institution, Moscow

111123

Local Institution, Moscow

115446

Local Institution, Moscow

117198

Local Institution, Moscow

117593

Local Institution, Moscow

127015

Local Institution, Moscow

194100

Local Institution, Saint Petersburg

198103

Local Institution, Saint Petersburg

355017

Local Institution, Stavropol

420012

Local Institution, Kazan'

40110-160

Local Institution, Salvador

80240-280

Local Institution, Curitiba

90035-003

Local Institution, Porto Alegre

18618-000

Local Institution, Botucatu

21040-000

Local Institution, Rio de Janeiro

04035-970

Local Institution, São Paulo

04035

Local Institution, São Paulo

T2N 4Z6

University Of Calgary, Calgary

V5Z 1H2

Liver And Intestinal Research Centre (Lair), Vancouver

V6Z 2K5

Gastrointestinal Research Institute (G.I.R.I.), Vancouver

V8V 3P9

Percuro Clinical Research Ltd, Victoria

M5G 2N2

Toronto General Hospital, Toronto

H1T 2M4

Hopital Maisonneuve-Rosemont, Montreal

500 05

Local Institution, Hradec Králové

120 00

Local Institution, Prague

140 21

Local Institution, Prague

00149

Local Institution, Roma

15-540

Local Institution, Bialystok

25-726

Local Institution, Kielce

41-400

Local Institution, Mysłowice

47-400

Local Institution, Racibórz

50-220

Local Institution, Wroclaw

37-100

Local Institution, Łańcut

03010

Local Institution, Alicante

B15 2TH

Local Institution, Birmingham

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY